This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Additional capacity broadens Grace’s fine chemical capabilities for API production
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
